Arena Pharmaceuticals Inc ARNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:33 PM EST
80.10UNCH (UNCH)
Volume
18,884
Close
80.10quote price arrow up+3.54 (+4.62%)
Volume
705,754
52 week range
32.95 - 90.19

...

Loading . . .

KEY STATS

  • Open75.97
  • Day High82.25
  • Day Low75.97
  • Prev Close76.56
  • 52 Week High90.19
  • 52 Week High Date11/04/20
  • 52 Week Low32.95
  • 52 Week Low Date03/18/20
  • Market Cap4.659B
  • Shares Out58.16M
  • 10 Day Average Volume0.44M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • 1 Year % Change62.56

RATIOS/PROFITABILITY

  • EPS (TTM)-7.39
  • P/E (TTM)-10.84
  • Fwd P/E (NTM)-10.22
  • EBITDA (MRQ)-381.428M
  • ROE (MRQ)-32.03%
  • Revenue (MRQ)3.28M
  • Gross Margin (MRQ)35.70%
  • Net Margin (MRQ)-11,293.67%
  • Debt To Equity (MRQ)3.98%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Arena Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the treatment of pain associated with Crohn's disease, and ralinepag (APD811) in Phase II evaluation for pulmonary arterial hypertension (PAH). The...
Garry Neil M.D.
Non-Executive Chairman
Amit Munshi
President
Laurie Stelzer CPA
Chief Financial Officer
Robert Lisicki
Executive Vice President
Joan Schmidt J.D.
Executive Vice President
Address
6154 Nancy Ridge Dr
San Diego, CA
92121-3223
United States